Trevi Therapeutics Inc (TRVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 24,698 | 29,113 | 36,830 | 29,318 | 36,425 |
| Marketable Securities | 53,157 | N/A | N/A | N/A | N/A |
| Other current assets | 382 | 249 | 241 | 0 | 0 |
| TOTAL | $79,885 | $29,839 | $37,957 | $30,707 | $38,480 |
| Non-Current Assets | |||||
| PPE Net | 34 | 42 | 53 | 66 | 78 |
| Investments And Advances | 1,000 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 495 | 505 | 465 | 823 | 591 |
| TOTAL | $1,529 | $547 | $518 | $889 | $669 |
| Total Assets | $81,414 | $30,386 | $38,475 | $31,596 | $39,149 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 7,000 | 7,000 | 5,833 | 4,083 | 2,333 |
| Accounts payable and accrued liabilities | 3,938 | 1,738 | 2,849 | 2,233 | 3,488 |
| Accrued Expenses | 4,403 | 3,881 | 3,808 | 3,314 | 3,316 |
| Other current liabilities | N/A | 125 | 114 | 167 | 162 |
| TOTAL | $15,433 | $12,867 | $12,724 | $9,913 | $9,410 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,428 | 7,056 | 8,652 | 10,245 | 11,912 |
| Other Non-Current Liabilities | 38 | 0 | 24 | 58 | 91 |
| TOTAL | $5,466 | $7,056 | $8,676 | $10,303 | $12,003 |
| Total Liabilities | $20,899 | $19,923 | $21,400 | $20,216 | $21,413 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 42,771 | 38,686 | 30,806 | 25,847 | 21,599 |
| Common Shares | 40 | 31 | 29 | 22 | 21 |
| Retained earnings | -196,298 | -188,246 | -180,917 | -172,397 | -165,142 |
| Other shareholders' equity | -135 | 0 | 0 | 0 | 0 |
| TOTAL | $60,515 | $10,463 | $17,075 | $11,380 | $17,736 |
| Total Liabilities And Equity | $81,414 | $30,386 | $38,475 | $31,596 | $39,149 |